55 results
424B3
RGTPQ
Polarityte, Inc.
1 Jul 22
Prospectus supplement
8:30am
in the structure of health care payment systems in the United States or overseas;
failure of any of our products or product candidates to perform safely
D
nrhyn9evyaw9roh
14 Jun 22
$11.6M in options, sold $4M, 1 investor
4:35pm
424B5
i8izg
7 Jun 22
Prospectus supplement for primary offering
4:30pm
424B5
naflg6d57nu5 o0y
16 Mar 22
Prospectus supplement for primary offering
4:00pm
8-K
EX-99.1
r4ebbfdg
18 Jan 22
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTEĀ® to
8:00am
8-K
e8c54om7o fjcqwvp
24 Aug 21
Departure of Directors or Certain Officers
8:00am
8-K
EX-10.3
z9otsouj4m4iqz1380
24 Aug 21
Departure of Directors or Certain Officers
8:00am
8-K
EX-10.1
b7z5an1n581la0y
24 Aug 21
Departure of Directors or Certain Officers
8:00am
8-K
EX-10.2
d2tom95p119n5k0a
24 Aug 21
Departure of Directors or Certain Officers
8:00am
8-K
yl4ri1a4ljrztjo2k647
26 Jul 21
Other Events
8:00am
424B5
yyqa 4lg30uvddxfzqn
26 Jan 21
Prospectus supplement for primary offering
4:15pm